SGH

Sivik Global Healthcare Portfolio holdings

AUM $224M
1-Year Est. Return 5.3%
This Quarter Est. Return
1 Year Est. Return
+5.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$40.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$4.49M
2
+$4.35M
3
+$4.34M
4
RGEN icon
Repligen
RGEN
+$3.73M
5
UHS icon
Universal Health Services
UHS
+$3.62M

Top Sells

1
+$5.14M
2
+$3.26M
3
+$3.03M
4
BSX icon
Boston Scientific
BSX
+$2.15M
5
CAH icon
Cardinal Health
CAH
+$840K

Sector Composition

1 Healthcare 90.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNN icon
26
Smith & Nephew
SNN
$15.4B
$4.29M 1.17%
140,000
+20,000
RGEN icon
27
Repligen
RGEN
$8.69B
$3.73M 1.02%
+30,000
WST icon
28
West Pharmaceutical
WST
$19.8B
$3.28M 0.89%
15,000
+2,500
EHC icon
29
Encompass Health
EHC
$12.6B
$3.07M 0.83%
25,000
-26,600
AVTR icon
30
Avantor
AVTR
$10.3B
$3.03M 0.82%
225,000
+25,000
ALGN icon
31
Align Technology
ALGN
$9.78B
$2.84M 0.77%
+15,000
SGRY icon
32
Surgery Partners
SGRY
$2.67B
$2.78M 0.76%
125,000
BAX icon
33
Baxter International
BAX
$11.9B
$2.27M 0.62%
75,000
-100,000
COO icon
34
Cooper Companies
COO
$14.9B
$2.13M 0.58%
+30,000
ALNY icon
35
Alnylam Pharmaceuticals
ALNY
$64.4B
$2.12M 0.58%
+6,500
MDGL icon
36
Madrigal Pharmaceuticals
MDGL
$9.81B
$1.51M 0.41%
+5,000
ARGX icon
37
argenx
ARGX
$52.3B
$1.38M 0.37%
+2,500
INSP icon
38
Inspire Medical Systems
INSP
$2.39B
$1.3M 0.35%
+10,000
AZN icon
39
AstraZeneca
AZN
$260B
– –
-70,000
SRPT icon
40
Sarepta Therapeutics
SRPT
$2.41B
– –
0
1
2